Effect of albuterol on maximal exercise capacity in cystic fibrosis

Chest

Volumn 131, Issue 4, 2007, Pages 1181-1187

  Serisier, David J ^a   Coates, Andrew D ^a   Bowler, Simon D ^a  

^a MATER ADULT HOSPITAL   (Australia)

Author keywords

Adrenergic agonists; Albuterol; Cystic fibrosis; Exercise; Salbutamol

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; DEOXYRIBONUCLEASE; SALBUTAMOL;

ADULT; AIRWAY OBSTRUCTION; ARTICLE; BICYCLE ERGOMETRY; BRONCHODILATATION; BRONCHODILATING ACTIVITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; CYSTIC FIBROSIS; DOUBLE BLIND PROCEDURE; EXERCISE TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 34247209759     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.06-1697     Document Type: Article

References (38)

1. Koch C, McKenzie SG, Kaplowitz H. International practice patterns by age and severity of lung disease in cystic fibrosis: data from the epidemiologic registry of cystic fibrosis (ERCF). Pediatr Pulmonol 1997; 24:147-154
2. Balfour-Lynn IM, Elborn JS. "CF asthma": what is it and what can we do about it? Thorax 2002; 57:742-748
3. Tobin MJ, Maguire O, Reen D, et al. Atopy and bronchial reactivity in older patients with cystic fibrosis. Thorax 1980; 35:807-813
4. Brand PL. Bronchodilators in cystic fibrosis. J R Soc Med 2000; 93(suppl 38):37-39
5. Hordvik NL, Konig P, Morris D, et al. A longitudinal study of bronchodilator responsiveness in cystic fibrosis. Am Rev Respir Dis 1985; 131:889-893
6. Zach MS, Oberwaldner B, Forche G, et al. Bronchodilators increase airway instability in cystic fibrosis. Am Rev Respir Dis 1985; 131:537-543
7. Zinman R, Wohl ME, Ingram RH. Nonhomogeneous lung emptying in cystic fibrosis patients. Am Rev Respir Dis 1991; 143:1257-1261
8. Bennett WD. Effect of β-adrenergic agonists on mucociliary clearance. J Allergy Clin Immunol 2002; 110(6 Suppl 1):S291-S297
9. 2-adrenergic agonists on lung mucociliary clearance in patients with cystic fibrosis. Chest 1993; 103:805-811
10. Nixon PA, Orenstein DM, Kelsey SF, et al. The prognostic value of exercise testing in patients with cystic fibrosis. N Engl J Med 1992; 327:1785-1788
11. Shah AR, Gozal D, Keens TG. Determinants of aerobic and anaerobic exercise performance in cystic fibrosis. Am J Respir Crit Care Med 1998; 157:1145-1150
12. De Meer K, Gulmans VAM, van der Laag J. Peripheral muscle weakness and exercise capacity in children with cystic fibrosis. Am J Respir Crit Care Med 1999; 159:748-754
13. Selvadurai HC, McKay KO, Blimkie CJ, et al. The relationship between genotype and exercise tolerance in children with cystic fibrosis. Am J Respir Crit Care Med 2002; 165:762-765
14. Moser C, Tirakitsoontorn P, Nussbaum E, et al. Muscle size and cardiorespiratory response to exercise in cystic fibrosis. Am J Respir Crit Care Med 2000; 162:1823-1827
15. Selvadurai HC, Allen J, Sachinwalla T, et al. Muscle function and resting energy expenditure in female athletes with cystic fibrosis. Am J Respir Crit Care Med 2003; 168:1476-1480
16. Klijn PHC, van der Net J, Kimpen JL, et al. Longitudinal determinants of peak aerobic performance in children with cystic fibrosis. Chest 2003; 124:2215-2219
17. Regnis JA, Donnelly PM, Robinson M, et al. Ventilatory mechanics at rest and during exercise in patients with cystic fibrosis. Am J Respir Crit Care Med 1996; 154:1418-1425
18. Liesker JJ, Wijkstra PJ, Ten Hacken NH, et al. A systematic review of the effects of bronchodilators on exercise capacity in patients with COPD. Chest 2002; 121:597-608
19. O'Donnell DE, Lam M, Webb KA. Measurement of symptoms, lung hyperinflation and endurance during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158:1557-1565
20. Hebestreit H, Kieser S, Rudiger S. Physical activity is independently related to exercise capacity in cystic fibrosis. Eur Respir J 2006; 28:734-739
21. Selvadurai HC, Blimkie CJ, Cooper PJ, et al. Gender differences in habitual activity in children with cystic fibrosis. Arch Dis Child 2004; 89:928-933
22. Dodd JD, Barry SC, Daly LE, et al. Inhaled β-agonists improve lung function but not maximal exercise capacity in cystic fibrosis. J Cyst Fibres 2005; 4:101-105
23. Eggleston PA, Rosenstein BJ, Stackhouse CM, et al. A controlled trial of long-term bronchodilator therapy in cystic fibrosis. Chest 1991; 99:1088-1092
24. McKone EF, Barry SC, Fitzgerald MX, et al. Reproducibility of maximal exercise ergometer testing in patients with cystic fibrosis. Chest 1999; 116:363-368
25. Yan K, Salome C, Woolcock AJ. Rapid method for measurement of bronchial responsiveness. Thorax 1983; 38:760-765
26. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995; 152:1107-1136
27. Wasserman K. Principles of exercise testing and interpretation. 3rd ed. Philadelphia, PA: Lippincott, Williams and Wilkins, 1999
28. Belman MJ, Botnick WC, Shin JW. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 153:967-975
29. Aliverti A, Rodger K, Dellaca RL, et al. The effect of salbutamol on lung function and chest wall volumes at rest and during exercise in COPD. Thorax 2005; 60:916-924
30. Stein R, Selvadurai H, Coates A, et al. Determination of maximal voluntary ventilation in children with cystic fibrosis. Pediatr Pulmonol 2003; 35:467-471
31. American Thoracic Society/American College of Chest Physicians. ATS/ACCP statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 2003; 167:211-277
32. Johnson BD, Weissman IM, Zeballos RJ, et al. Emerging concepts in the evaluation of ventilatory limitation during exercise. Chest 1999; 116:488-503
33. McKone EF, Bary SC, FitzGerald MX, et al. Role of arterial hypoxaemia and pulmonary mechanics in exercise limitation in cystic fibrosis. J Appl Physiol 2005; 99:1012-1018
34. Viegas CA, Ferrer A, Montserrat JM, et al. Ventilation-perfusion response after fenoterol in hypoxemic patients with stable COPD. Chest 1996; 110:71-77
35. 2 extraction by canine skeletal muscle. Adv Exp Med Biol 1990; 277:569-575
36. Kusenbach G, Friedrichs F, Skopnik H, et al. Increased physiological dead space during exercise after bronchodilation in cystic fibrosis. Pediatr Pulmonol 1993; 15:273-278
37. Oga T, Nishimura K, Tsukino M, et al. The effects of oxitropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 161:1897-1901
38. Pepin V, Saey D, Whittom F, et al. Walking versus cycling: sensitivity to bronchodilation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 172:1517-1522